New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy

Over the last 20 years, granulocyte colony-stimulating factors (G-CSFs) have become the major therapeutic option for the treatment of patients with neutropenia. Most of the current G-CSFs require daily injections, which are inconvenient and expensive for patients. Increased understanding of G-CSFs’...

Descripción completa

Detalles Bibliográficos
Autores principales: Theyab, Abdulrahman, Alsharif, Khalaf F., Alzahrani, Khalid J., Oyouni, Atif Abdulwahab A., Hawsawi, Yousef MohammedRabaa, Algahtani, Mohammad, Alghamdi, Saad, Alshammary, Amal F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850083/
https://www.ncbi.nlm.nih.gov/pubmed/36686781
http://dx.doi.org/10.3389/fonc.2022.1026377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850083/
https://www.ncbi.nlm.nih.gov/pubmed/36686781
http://dx.doi.org/10.3389/fonc.2022.1026377

Ejemplares similares